SCHEMBL7184299

SCHEMBL7184299

CCCOc1ccc(OCCC)c(C=CC(=O)c2ccc(OC)cc2)c1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.67
DPP4 P27487 6/20 0.65
CYP1A1 P04798 1/20 0.64
CYP1B1 Q16678 1/20 0.64
KDM4E B2RXH2 1/20 0.60
LMNA P02545 1/20 0.60
MAPT P10636 1/20 0.60
ATM Q13315 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
PTPN1 P18031 3/20 0.59
TNFRSF1A P19438 2/20 0.59
GABRA3 P34903 1/20 0.59
GABRA2 P47869 1/20 0.59
GABRB2 P47870 1/20 0.59
MAOB P27338 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7191866 0.95 ABCG2 (0.67) ABCG2DPP4CYP1A1CYP1B1KDM4E
SCHEMBL9115209 0.91 CYP1A1 (0.72) ABCG2DPP4CYP1A1CYP1B1LMNA
SCHEMBL7191189 0.90 DPP4 (0.62) ABCG2DPP4CYP1A1CYP1B1KDM4E
SCHEMBL9114554 0.89 CYP1A1 (0.61) ABCG2DPP4CYP1A1CYP1B1KDM4E
SCHEMBL7180758 0.89 ABCG2 (0.69) ABCG2DPP4CYP1A1CYP1B1KDM4E
SCHEMBL7180753 0.89 ABCG2 (0.69) ABCG2DPP4CYP1A1CYP1B1KDM4E
SCHEMBL8442123 0.88 ABCG2 (0.64) ABCG2DPP4CYP1A1CYP1B1KDM4E
SCHEMBL9113194 0.87 DPP4 (0.59) ABCG2DPP4CYP1A1CYP1B1KDM4E
SCHEMBL9113143 0.86 TNFRSF1A (0.68) ABCG2DPP4CYP1A1CYP1B1LMNA
SCHEMBL9112484 0.86 CYP1A1 (0.58) ABCG2DPP4CYP1A1CYP1B1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed